US Stock MarketDetailed Quotes

BridgeBio Pharma (BBIO)

Watchlist
  • 68.560
  • -2.550-3.59%
Close May 1 16:00 ET
  • 68.350
  • -0.210-0.31%
Post 20:01 ET
13.42BMarket Cap-18.14P/E (TTM)

BridgeBio Pharma (BBIO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
14.37%-445.91M
71.11%-56.42M
39.32%-109.57M
-208.00%-80.68M
9.25%-199.24M
1.33%-520.73M
-56.49%-195.33M
-24.33%-180.57M
165.90%74.7M
-52.12%-219.54M
Net income from continuing operations
-34.89%-732.94M
27.21%-194.64M
-12.59%-184.94M
-143.25%-183.76M
-369.05%-169.61M
16.82%-543.35M
-56.98%-267.39M
8.49%-164.25M
52.99%-75.54M
74.67%-36.16M
Operating gains losses
166.00%84.93M
85.85%31.03M
98.47%-695K
115.11%17.89M
98.93%36.71M
-653.73%-128.68M
280.19%16.7M
-146,558.06%-45.46M
-6,263.92%-118.37M
411.88%18.45M
Depreciation and amortization
-10.55%5.43M
4.97%1.44M
-9.10%1.4M
-16.33%1.32M
-19.55%1.28M
-6.45%6.08M
-13.75%1.37M
-6.16%1.54M
-3.85%1.57M
-2.27%1.6M
Other non cash items
584.38%136.01M
219.11%42.81M
1,570.35%43.33M
3,301.18%27.21M
380.64%22.66M
-14.14%19.87M
91.96%13.41M
-17.39%2.59M
-112.83%-850K
-26.27%4.72M
Change In working capital
-259.37%-51.06M
283.24%49.61M
-83.52%-3.93M
-92.12%19.42M
48.42%-116.17M
533.62%32.04M
-41.10%12.95M
-263.39%-2.14M
1,716.18%246.44M
-608.13%-225.2M
-Change in receivables
-4,434.57%-134.72M
-440.20%-22.93M
-21,885.71%-39.65M
-83.65%38.4M
52.71%-110.54M
-119.38%-2.97M
-224.13%-4.24M
-94.71%182K
10,832.68%234.83M
-3,799.64%-233.74M
-Change in inventory
---25.31M
---1.95M
---6.77M
---13.39M
---3.19M
--0
--0
--0
--0
--0
-Change in prepaid assets
36.94%-8.78M
141.38%8.75M
147.28%5.22M
-604.14%-22.26M
85.44%-487K
-415.10%-13.92M
310.51%3.63M
-441.83%-11.04M
-168.73%-3.16M
5.56%-3.35M
-Change in payables and accrued expense
108.59%56.79M
4,616.99%44.15M
-21.36%14.74M
-98.05%336K
74.98%-2.43M
3,645.12%27.23M
-95.72%936K
1,770.66%18.74M
93.32%17.28M
68.72%-9.73M
-Change in other current assets
-27.82%1.11M
-72.34%545K
154.16%742K
-453.61%-1.76M
257.43%1.59M
199.74%1.54M
165.91%1.97M
-197.09%-1.37M
-3.30%498K
191.93%444K
-Change in other current liabilities
-10.93%-6.55M
-1,160.55%-54.82M
454.01%24.78M
1,904.67%22.02M
151.74%1.48M
-22.22%-5.9M
546.37%5.17M
-470.03%-7M
-2.26%-1.22M
-128.08%-2.85M
-Change in other working capital
154.69%66.38M
1,282.07%75.86M
-79.95%-2.99M
-119.24%-3.92M
-110.70%-2.57M
1,456.79%26.06M
115.85%5.49M
-29.77%-1.66M
-24.51%-1.79M
1,474.37%24.02M
Cash from discontinued investing activities
Operating cash flow
14.37%-445.91M
71.11%-56.42M
39.32%-109.57M
-208.00%-80.68M
9.25%-199.24M
1.33%-520.73M
-56.49%-195.33M
-24.33%-180.57M
165.90%74.7M
-52.12%-219.54M
Investing cash flow
Cash flow from continuing investing activities
-140.29%-24.49M
-343.44%-14.35M
-88.32%4.46M
-527.84%-13M
-107.01%-1.6M
12.49%60.78M
-4,804.55%-3.24M
1.44%38.23M
-26.22%3.04M
85.01%22.75M
Net PPE purchase and sale
-17.58%-1.1M
29.79%-33K
-243.07%-470K
-1,000.00%-594K
--0
28.56%-933K
89.20%-47K
68.21%-137K
87.38%-54K
-5,691.67%-695K
Net intangibles purchase and sale
-6.52%-8.5M
--0
-50.47%-2.4M
-88.05%-4.5M
-100.13%-1.6M
---7.98M
---3.19M
---1.6M
---2.39M
---797K
Net business purchase and sale
--0
--0
--0
----
----
72.17%-140K
--0
---42K
---98K
--0
Net investment purchase and sale
-138.95%-17.2M
---14.32M
-87.42%5.03M
-241.62%-7.91M
--0
-20.94%44.15M
--0
4.95%40M
22.81%5.58M
-111.22%-1.44M
Cash from discontinued investing activities
Investing cash flow
-140.29%-24.49M
-343.44%-14.35M
-88.32%4.46M
-527.84%-13M
-107.01%-1.6M
12.49%60.78M
-4,804.55%-3.24M
1.44%38.23M
-26.22%3.04M
85.01%22.75M
Financing cash flow
Cash flow from continuing financing activities
-52.00%359.29M
-100.46%-2.18M
-226.45%-894K
5,372.14%302.04M
-78.42%60.33M
65.76%748.46M
10,578.24%473.93M
-99.77%707K
-365.39%-5.73M
86.06%279.55M
Net issuance payments of debt
595.37%116M
--0
---300M
--300M
595.37%116M
---23.42M
--0
--0
--0
---23.42M
Net common stock issuance
-120.34%-62.5M
-429.20%-7.43M
-107.05%-3.03M
10.86%-2M
-116.03%-50.05M
-30.64%307.22M
53.34%-1.4M
-100.48%-1.46M
-1,216.47%-2.24M
119.16%312.32M
Proceeds from stock option exercised by employees
318.60%34.15M
363.90%13.21M
269.93%8.02M
2,870.54%7.16M
98.48%5.76M
-13.27%8.16M
261.88%2.85M
-66.64%2.17M
102.52%241K
44.91%2.9M
Net other financing activities
-40.49%271.65M
-101.69%-7.96M
--294.11M
16.32%-3.12M
7.15%-11.38M
57,091.39%456.5M
20,633.99%472.49M
--0
-216.27%-3.73M
-313.37%-12.25M
Cash from discontinued financing activities
Financing cash flow
-52.00%359.29M
-100.46%-2.18M
-226.45%-894K
5,372.14%302.04M
-78.42%60.33M
65.76%748.46M
10,578.24%473.93M
-99.77%707K
-365.39%-5.73M
86.06%279.55M
Net cash flow
Beginning cash position
73.09%683.24M
58.16%645.1M
36.69%751.1M
13.66%542.74M
73.09%683.24M
-5.31%394.73M
-22.18%407.88M
69.27%549.51M
9.74%477.5M
-5.31%394.73M
Current changes in cash
-138.51%-111.1M
-126.49%-72.96M
25.16%-106M
189.33%208.36M
-269.76%-140.5M
1,402.42%288.51M
312.79%275.37M
-171.00%-141.63M
165.19%72.01M
354.12%82.76M
End cash Position
-16.26%572.14M
-16.26%572.14M
58.16%645.1M
36.69%751.1M
13.66%542.74M
73.09%683.24M
73.09%683.24M
-22.18%407.88M
69.27%549.51M
9.74%477.5M
Free cash flow
14.00%-455.5M
71.57%-56.45M
38.32%-112.44M
-218.71%-85.78M
9.14%-200.83M
-0.11%-529.63M
-58.53%-198.56M
-25.16%-182.3M
163.50%72.26M
-53.14%-221.03M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 14.37%-445.91M71.11%-56.42M39.32%-109.57M-208.00%-80.68M9.25%-199.24M1.33%-520.73M-56.49%-195.33M-24.33%-180.57M165.90%74.7M-52.12%-219.54M
Net income from continuing operations -34.89%-732.94M27.21%-194.64M-12.59%-184.94M-143.25%-183.76M-369.05%-169.61M16.82%-543.35M-56.98%-267.39M8.49%-164.25M52.99%-75.54M74.67%-36.16M
Operating gains losses 166.00%84.93M85.85%31.03M98.47%-695K115.11%17.89M98.93%36.71M-653.73%-128.68M280.19%16.7M-146,558.06%-45.46M-6,263.92%-118.37M411.88%18.45M
Depreciation and amortization -10.55%5.43M4.97%1.44M-9.10%1.4M-16.33%1.32M-19.55%1.28M-6.45%6.08M-13.75%1.37M-6.16%1.54M-3.85%1.57M-2.27%1.6M
Other non cash items 584.38%136.01M219.11%42.81M1,570.35%43.33M3,301.18%27.21M380.64%22.66M-14.14%19.87M91.96%13.41M-17.39%2.59M-112.83%-850K-26.27%4.72M
Change In working capital -259.37%-51.06M283.24%49.61M-83.52%-3.93M-92.12%19.42M48.42%-116.17M533.62%32.04M-41.10%12.95M-263.39%-2.14M1,716.18%246.44M-608.13%-225.2M
-Change in receivables -4,434.57%-134.72M-440.20%-22.93M-21,885.71%-39.65M-83.65%38.4M52.71%-110.54M-119.38%-2.97M-224.13%-4.24M-94.71%182K10,832.68%234.83M-3,799.64%-233.74M
-Change in inventory ---25.31M---1.95M---6.77M---13.39M---3.19M--0--0--0--0--0
-Change in prepaid assets 36.94%-8.78M141.38%8.75M147.28%5.22M-604.14%-22.26M85.44%-487K-415.10%-13.92M310.51%3.63M-441.83%-11.04M-168.73%-3.16M5.56%-3.35M
-Change in payables and accrued expense 108.59%56.79M4,616.99%44.15M-21.36%14.74M-98.05%336K74.98%-2.43M3,645.12%27.23M-95.72%936K1,770.66%18.74M93.32%17.28M68.72%-9.73M
-Change in other current assets -27.82%1.11M-72.34%545K154.16%742K-453.61%-1.76M257.43%1.59M199.74%1.54M165.91%1.97M-197.09%-1.37M-3.30%498K191.93%444K
-Change in other current liabilities -10.93%-6.55M-1,160.55%-54.82M454.01%24.78M1,904.67%22.02M151.74%1.48M-22.22%-5.9M546.37%5.17M-470.03%-7M-2.26%-1.22M-128.08%-2.85M
-Change in other working capital 154.69%66.38M1,282.07%75.86M-79.95%-2.99M-119.24%-3.92M-110.70%-2.57M1,456.79%26.06M115.85%5.49M-29.77%-1.66M-24.51%-1.79M1,474.37%24.02M
Cash from discontinued investing activities
Operating cash flow 14.37%-445.91M71.11%-56.42M39.32%-109.57M-208.00%-80.68M9.25%-199.24M1.33%-520.73M-56.49%-195.33M-24.33%-180.57M165.90%74.7M-52.12%-219.54M
Investing cash flow
Cash flow from continuing investing activities -140.29%-24.49M-343.44%-14.35M-88.32%4.46M-527.84%-13M-107.01%-1.6M12.49%60.78M-4,804.55%-3.24M1.44%38.23M-26.22%3.04M85.01%22.75M
Net PPE purchase and sale -17.58%-1.1M29.79%-33K-243.07%-470K-1,000.00%-594K--028.56%-933K89.20%-47K68.21%-137K87.38%-54K-5,691.67%-695K
Net intangibles purchase and sale -6.52%-8.5M--0-50.47%-2.4M-88.05%-4.5M-100.13%-1.6M---7.98M---3.19M---1.6M---2.39M---797K
Net business purchase and sale --0--0--0--------72.17%-140K--0---42K---98K--0
Net investment purchase and sale -138.95%-17.2M---14.32M-87.42%5.03M-241.62%-7.91M--0-20.94%44.15M--04.95%40M22.81%5.58M-111.22%-1.44M
Cash from discontinued investing activities
Investing cash flow -140.29%-24.49M-343.44%-14.35M-88.32%4.46M-527.84%-13M-107.01%-1.6M12.49%60.78M-4,804.55%-3.24M1.44%38.23M-26.22%3.04M85.01%22.75M
Financing cash flow
Cash flow from continuing financing activities -52.00%359.29M-100.46%-2.18M-226.45%-894K5,372.14%302.04M-78.42%60.33M65.76%748.46M10,578.24%473.93M-99.77%707K-365.39%-5.73M86.06%279.55M
Net issuance payments of debt 595.37%116M--0---300M--300M595.37%116M---23.42M--0--0--0---23.42M
Net common stock issuance -120.34%-62.5M-429.20%-7.43M-107.05%-3.03M10.86%-2M-116.03%-50.05M-30.64%307.22M53.34%-1.4M-100.48%-1.46M-1,216.47%-2.24M119.16%312.32M
Proceeds from stock option exercised by employees 318.60%34.15M363.90%13.21M269.93%8.02M2,870.54%7.16M98.48%5.76M-13.27%8.16M261.88%2.85M-66.64%2.17M102.52%241K44.91%2.9M
Net other financing activities -40.49%271.65M-101.69%-7.96M--294.11M16.32%-3.12M7.15%-11.38M57,091.39%456.5M20,633.99%472.49M--0-216.27%-3.73M-313.37%-12.25M
Cash from discontinued financing activities
Financing cash flow -52.00%359.29M-100.46%-2.18M-226.45%-894K5,372.14%302.04M-78.42%60.33M65.76%748.46M10,578.24%473.93M-99.77%707K-365.39%-5.73M86.06%279.55M
Net cash flow
Beginning cash position 73.09%683.24M58.16%645.1M36.69%751.1M13.66%542.74M73.09%683.24M-5.31%394.73M-22.18%407.88M69.27%549.51M9.74%477.5M-5.31%394.73M
Current changes in cash -138.51%-111.1M-126.49%-72.96M25.16%-106M189.33%208.36M-269.76%-140.5M1,402.42%288.51M312.79%275.37M-171.00%-141.63M165.19%72.01M354.12%82.76M
End cash Position -16.26%572.14M-16.26%572.14M58.16%645.1M36.69%751.1M13.66%542.74M73.09%683.24M73.09%683.24M-22.18%407.88M69.27%549.51M9.74%477.5M
Free cash flow 14.00%-455.5M71.57%-56.45M38.32%-112.44M-218.71%-85.78M9.14%-200.83M-0.11%-529.63M-58.53%-198.56M-25.16%-182.3M163.50%72.26M-53.14%-221.03M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More